Effects of a tailored dose of varenicline on post-quitting urges to smoke - Tailoring varenicline to individual needs (TVIN)
- Conditions
- Tobacco dependence (smoking cessation)
- Registration Number
- EUCTR2010-022335-11-GB
- Lead Sponsor
- Barts and the London School of Medicine and Dentistry, Queen Mary University of London
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 0
Smokers seeking treatment, aged 18 and over, consenting to take part in the trial. Only those who report ratings of 4 or less on the enjoyment question and 2 or less on the nausea question at session 2 will be randomised.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Pregnant or breastfeeding, end-stage renal disease, current psychiatric illness, severe heart condition, previous allergic reaction to varenicline, unable to fill out the questionnaire in English, is unable to attend the randomisation visit or currently taking part in a research study.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method